Spain’s SpliceBio will use $135 million from a series B round backed by Sanofi and Roche to advance its lead gene editing ...

Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...

Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...

Terumo Vietnam Medical Equipment (Terumo Vietnam) and Sanofi-Aventis Vietnam signed a two-year cooperation agreement to ...

Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investorsProceeds will support clinical development ...

BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden ...

S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...

Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

During a live event, Gary J. Schiller, MD, explored the outcomes of the phase 1/2 trial of tagraxofusp-erzs in patients with ...

As Head of R&D and a member of the Executive Leadership Team, the Company's research, development and medical affairs ...

ABUJA, NIGERIA / ACCESS Newswire / June 10, 2025 / In an era where healthcare disparities continue to challenge communities worldwide, five visionary pharmacists are making remarkable strides in revol ...